Evidence map›Paper›PMID 37020671›Full record

ArticleClinical case reports2023

Posterior reversible encephalopathy syndrome in SARS-CoV-2 infection: A case report and review of literature.

Mahsa Ziaee, Maryam Saeedi, Mohammad Rohani, Masoud Mehrpour, Bahram Haghi Ashtiani, Babak Zamani, Fahimeh Haji Akhoundi, Misagh Salahi Khalaf, Seyyedmohammadsadeq Mirmoeeni, Amirhossein Azari Jafari and 1 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Mahsa ZiaeeDepartment of Neurology Firoozgar Hospital, Iran University of Medical Sciences Tehran Iran.
Maryam SaeediDepartment of Neurology Shahroud University of Medical Sciences Shahroud Iran.
Mohammad RohaniDepartment of Neurology Hazrat Rasool Hospital, Iran University of Medical Sciences Tehran Iran.
Masoud MehrpourDepartment of Neurology Shahid Beheshti Medical University Tehran Iran.
Bahram Haghi AshtianiDepartment of Neurology Firoozgar Hospital, Iran University of Medical Sciences Tehran Iran.
Babak ZamaniDepartment of Neurology Firoozgar Hospital, Iran University of Medical Sciences Tehran Iran.
Fahimeh Haji AkhoundiDepartment of Neurology Firoozgar Hospital, Iran University of Medical Sciences Tehran Iran.
Misagh Salahi KhalafStudent Research Committee, School of Medicine Shahroud University of Medical Sciences Shahroud Iran.
Seyyedmohammadsadeq MirmoeeniStudent Research Committee, School of Medicine Shahroud University of Medical Sciences Shahroud Iran.ORCID https://orcid.org/0000-0002-5593-3743
Amirhossein Azari JafariStudent Research Committee, School of Medicine Shahroud University of Medical Sciences Shahroud Iran.ORCID https://orcid.org/0000-0003-3630-5028
Zahra ShateriStudent Research Committee, School of Medicine Shahroud University of Medical Sciences Shahroud Iran.
Iran University of Medical Sciences · IRShahroud University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Consider PRES in SARS-CoV-2 infected patients who develop encephalopathy, seizures or impaired vision; especially if the disease is complicated by respiratory distress and need for mechanical ventilation.

Indexed as

COVID‐19posterior reversible leukoencephalopathy syndromePRESSARS‐CoV2

Identifiers

PMID37020671
PMCPMC10067803
OpenAlexW4362577587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.